Showing results (1851-1860 of 2,148) with videos related to
Sort By:
Pageof 215
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 22, 2024
What does it mean to be "healthy" when taking elexacaftor/tezacaftor/ivacaftor (ETI)? A qualitative studyRobin S Everhart, Emma McWilliams, Jill Maggs, et al.Rheumatology (Oxford, England)|January 28, 2026
Evaluation of a screening algorithm to detect systemic sclerosis-related myopathyVandana Bhushan, Vidya Limaye, Dylan Hansen, et al.Cancer|August 24, 2012
A randomized phase 2 study of temozolomide and bevacizumab or nab-paclitaxel, carboplatin, and bevacizumab in patients with unresectable stage IV melanoma : a North Central Cancer Treatment Group study, N0775Lisa A Kottschade, Vera J Suman, Domingo G Perez, et al.Urologic Oncology|July 25, 2016
Unmet informational and supportive care needs of patients following cystectomy for bladder cancer based on age, sex, and treatment choicesNihal E Mohamed, Sailaja Pisipati, Cheryl T Lee, et al.Plos One|March 9, 2010
A crucial role for Kupffer cell-derived galectin-9 in regulation of T cell immunity in hepatitis C infectionJohn A Mengshol, Lucy Golden-Mason, Tomohiro Arikawa, et al.BMJ Open|September 10, 2025
Youth Med.Info: a case study in co-design of mental health medicines-information resources for children, young people and their parents/guardiansCaroline Hynes-Ryan, Ian Kelleher, Sophie Kathryn, et al.Oncogene|October 11, 2001
BRCA1 and GADD45 mediated G2/M cell cycle arrest in response to antimicrotubule agentsP B Mullan, J E Quinn, P M Gilmore, et al.Investigational New Drugs|October 12, 2013
UGT1A1 genotype-guided phase I study of irinotecan, oxaliplatin, and capecitabineMatthew P Goetz, Heidi A McKean, Joel M Reid, et al.Medrxiv : the Preprint Server for Health Sciences|July 15, 2024
The FLuorometholone as Adjunctive MEdical Therapy for Trachomatous Trichiasis Surgery (FLAME) Trial: Study DesignAhlam Awad Mohammed, Aida Abashawl, Sarity Dodson, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|August 21, 2025
"Time out for an hour, every day, my whole life": understanding treatment burden in cystic fibrosis in the era of Elexacaftor/Tezacaftor/Ivacaftor (ETI)Jennifer L Butcher, Christopher Siracusa, Hannah Grabowski, et al.Pageof 215